Personalized Cancer Medicine Market, Global Outlook and Forecast 2022-2028

Abstract
Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
This report contains market size and forecasts of Personalized Cancer Medicine in Global, including the following market information:

Global Personalized Cancer Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Personalized Cancer Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Personalized Cancer Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Personalized Cancer Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Personalized Cancer Medicine Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Personalized Cancer Vaccines
Other
Global Personalized Cancer Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Personalized Cancer Medicine Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer
Global Personalized Cancer Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Personalized Cancer Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Personalized Cancer Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Personalized Cancer Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda

Content
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Personalized Cancer Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Cancer Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Cancer Medicine Overall Market Size
2.1 Global Personalized Cancer Medicine Market Size: 2021 VS 2028
2.2 Global Personalized Cancer Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Cancer Medicine Players in Global Market
3.2 Top Global Personalized Cancer Medicine Companies Ranked by Revenue
3.3 Global Personalized Cancer Medicine Revenue by Companies
3.4 Top 3 and Top 5 Personalized Cancer Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Personalized Cancer Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Cancer Medicine Players in Global Market
3.6.1 List of Global Tier 1 Personalized Cancer Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Personalized Cancer Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Personalized Cancer Medicine Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Personalized Cancer Vaccines
4.1.4 Other
4.2 By Type - Global Personalized Cancer Medicine Revenue & Forecasts
4.2.1 By Type - Global Personalized Cancer Medicine Revenue, 2017-2022
4.2.2 By Type - Global Personalized Cancer Medicine Revenue, 2023-2028
4.2.3 By Type - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Personalized Cancer Medicine Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Chronic Myeloid Leukaemia
5.1.5 Bowel Cancer
5.1.6 Other Cancer
5.2 By Application - Global Personalized Cancer Medicine Revenue & Forecasts
5.2.1 By Application - Global Personalized Cancer Medicine Revenue, 2017-2022
5.2.2 By Application - Global Personalized Cancer Medicine Revenue, 2023-2028
5.2.3 By Application - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Personalized Cancer Medicine Market Size, 2021 & 2028
6.2 By Region - Global Personalized Cancer Medicine Revenue & Forecasts
6.2.1 By Region - Global Personalized Cancer Medicine Revenue, 2017-2022
6.2.2 By Region - Global Personalized Cancer Medicine Revenue, 2023-2028
6.2.3 By Region - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Personalized Cancer Medicine Revenue, 2017-2028
6.3.2 US Personalized Cancer Medicine Market Size, 2017-2028
6.3.3 Canada Personalized Cancer Medicine Market Size, 2017-2028
6.3.4 Mexico Personalized Cancer Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Personalized Cancer Medicine Revenue, 2017-2028
6.4.2 Germany Personalized Cancer Medicine Market Size, 2017-2028
6.4.3 France Personalized Cancer Medicine Market Size, 2017-2028
6.4.4 U.K. Personalized Cancer Medicine Market Size, 2017-2028
6.4.5 Italy Personalized Cancer Medicine Market Size, 2017-2028
6.4.6 Russia Personalized Cancer Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Personalized Cancer Medicine Market Size, 2017-2028
6.4.8 Benelux Personalized Cancer Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Personalized Cancer Medicine Revenue, 2017-2028
6.5.2 China Personalized Cancer Medicine Market Size, 2017-2028
6.5.3 Japan Personalized Cancer Medicine Market Size, 2017-2028
6.5.4 South Korea Personalized Cancer Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Personalized Cancer Medicine Market Size, 2017-2028
6.5.6 India Personalized Cancer Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Personalized Cancer Medicine Revenue, 2017-2028
6.6.2 Brazil Personalized Cancer Medicine Market Size, 2017-2028
6.6.3 Argentina Personalized Cancer Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Personalized Cancer Medicine Revenue, 2017-2028
6.7.2 Turkey Personalized Cancer Medicine Market Size, 2017-2028
6.7.3 Israel Personalized Cancer Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Personalized Cancer Medicine Market Size, 2017-2028
6.7.5 UAE Personalized Cancer Medicine Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Personalized Cancer Medicine Major Product Offerings
7.1.4 Abbott Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Personalized Cancer Medicine Major Product Offerings
7.2.4 Merck Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Personalized Cancer Medicine Major Product Offerings
7.3.4 Novartis Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Personalized Cancer Medicine Major Product Offerings
7.4.4 Amgen Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.4.5 Amgen Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Personalized Cancer Medicine Major Product Offerings
7.5.4 Celgene Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Bayer
7.6.1 Bayer Corporate Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Personalized Cancer Medicine Major Product Offerings
7.6.4 Bayer Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.6.5 Bayer Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Personalized Cancer Medicine Major Product Offerings
7.7.4 Roche Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.7.5 Roche Key News
7.8 Astellas
7.8.1 Astellas Corporate Summary
7.8.2 Astellas Business Overview
7.8.3 Astellas Personalized Cancer Medicine Major Product Offerings
7.8.4 Astellas Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.8.5 Astellas Key News
7.9 Astrazeneca
7.9.1 Astrazeneca Corporate Summary
7.9.2 Astrazeneca Business Overview
7.9.3 Astrazeneca Personalized Cancer Medicine Major Product Offerings
7.9.4 Astrazeneca Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.9.5 Astrazeneca Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Personalized Cancer Medicine Major Product Offerings
7.10.4 Johnson & Johnson Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.10.5 Johnson & Johnson Key News
7.11 Agilent
7.11.1 Agilent Corporate Summary
7.11.2 Agilent Business Overview
7.11.3 Agilent Personalized Cancer Medicine Major Product Offerings
7.11.4 Agilent Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.11.5 Agilent Key News
7.12 Takeda
7.12.1 Takeda Corporate Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Personalized Cancer Medicine Major Product Offerings
7.12.4 Takeda Personalized Cancer Medicine Revenue in Global Market (2017-2022)
7.12.5 Takeda Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Personalized Cancer Medicine Market Opportunities & Trends in Global Market
Table 2. Personalized Cancer Medicine Market Drivers in Global Market
Table 3. Personalized Cancer Medicine Market Restraints in Global Market
Table 4. Key Players of Personalized Cancer Medicine in Global Market
Table 5. Top Personalized Cancer Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Personalized Cancer Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Personalized Cancer Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Personalized Cancer Medicine Product Type
Table 9. List of Global Tier 1 Personalized Cancer Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Personalized Cancer Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Personalized Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Personalized Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Personalized Cancer Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Personalized Cancer Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Personalized Cancer Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Personalized Cancer Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Personalized Cancer Medicine Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Personalized Cancer Medicine Product Offerings
Table 32. Abbott Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Personalized Cancer Medicine Product Offerings
Table 35. Merck Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Personalized Cancer Medicine Product Offerings
Table 38. Novartis Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Personalized Cancer Medicine Product Offerings
Table 41. Amgen Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Personalized Cancer Medicine Product Offerings
Table 44. Celgene Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Bayer Corporate Summary
Table 46. Bayer Personalized Cancer Medicine Product Offerings
Table 47. Bayer Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Personalized Cancer Medicine Product Offerings
Table 50. Roche Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 51. Astellas Corporate Summary
Table 52. Astellas Personalized Cancer Medicine Product Offerings
Table 53. Astellas Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Astrazeneca Corporate Summary
Table 55. Astrazeneca Personalized Cancer Medicine Product Offerings
Table 56. Astrazeneca Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Personalized Cancer Medicine Product Offerings
Table 59. Johnson & Johnson Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 60. Agilent Corporate Summary
Table 61. Agilent Personalized Cancer Medicine Product Offerings
Table 62. Agilent Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)
Table 63. Takeda Corporate Summary
Table 64. Takeda Personalized Cancer Medicine Product Offerings
Table 65. Takeda Personalized Cancer Medicine Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Personalized Cancer Medicine Segment by Type in 2021
Figure 2. Personalized Cancer Medicine Segment by Application in 2021
Figure 3. Global Personalized Cancer Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Personalized Cancer Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Personalized Cancer Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2021
Figure 8. By Type - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 12. US Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 24. China Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Personalized Cancer Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Personalized Cancer Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Astellas Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Astrazeneca Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Agilent Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Takeda Personalized Cancer Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)